In summary, we hypothesize that miR‐217 may mediate the progression of DCIS by promoting the methylation of the TSHZ2 gene promoter region, thereby influencing the Hedgehog‐GLI signaling pathway. Here, TSHZ2 is linked to ductal breast carcinoma in situ.